药物信息为EPOPROSTENOL (GeneraMedix Inc ): INDICATIONS AND USAGE
- INDICATIONS AND USAGE
- DOSAGE AND ADMINISTRATION
- DOSAGE FORMS AND STRENGTHS
- CONTRAINDICATIONS
- DRUG INTERACTIONS
- OVERDOSAGE
- DESCRIPTION
- PATIENT COUNSELING INFORMATION
- Diseases/Conditions Related to EPOPROSTENOL (GeneraMedix Inc )
- 外部链接相关的EPOPROSTENOL (GeneraMedix Inc )
Epoprostenol is indicated for:
- the long-term intravenous treatment of primary pulmonary hypertension
- and pulmonary hypertension associated with the scleroderma spectrum of disease in NYHA Class III and Class IV patients who do not respond adequately to conventional therapy
- [see CLINICAL STUDIES: Clinical Trials in Pulmonary Hypertension (14.1) ].
- Drug Information Provided by National Library of Medicine (NLM).
这个站点被设计主要作为提示系统供合格的医师和其他医疗专家使用。 通过使用这个站点您了解并且接受DiagnosisPro.com不会使用作为一个诊断决策系统，并且不能使用做一个临床诊断或替换或者否决一位被准许的医疗保健专家的评断或临床诊断 (充分的使用条款). 我们遵循健康网络基金会的 医学和健康网站的行为准则. 点击这里核实
© 2013 MedTech USA, Inc. (最后更新在06/12/13)
